| STANDARD BIOTOOLS |
| USA |
| Gesundheit |
| US34385P1084 / A0RADJ |
| FLB (Frankfurt) / LAB (NASDAQ) |
| FRA:FLB, ETR:FLB, FLB:GR, NASDAQ:LAB |
| - |
| https://www.standardbio.c.. |
|
Standard Biotools Inc. is a leading developer and provider of innovative life sciences tools and solutions. This company focuses on empowering researchers by delivering precision instruments and systems essential for high-throughput DNA sequencing, p..
>Volltext.. |
| 310.32 Mio. EUR |
| 176.92 Mio. EUR |
| 91.75 Mio. EUR |
| -78.25 Mio. EUR |
| -64.88 Mio. EUR |
| -0.17 EUR |
| 26.71 Mio. EUR |
| 104.71 Mio. EUR |
| -64.4 Mio. EUR |
| 1.73 |
| -46.49% |
| 52.47% |
| - |
| - |
| - |
| - |
| STANDARD BIOTOOLS, STANDARD BIO |
| 04.04.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|